• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Moderate seafood consumption associated with decreased risk of Alzheimer pathology

byJohn PrendergassandMichael Milligan
February 3, 2016
in Chronic Disease, Neurology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Seafood consumption (>1 meal/week) associated with decreased Alzheimer disease neuropathology among apolipoprotein E (APOE ε4) carriers.

2. Cortical mercury and selenium levels were positively correlated with the number of seafood meals consumed per week.

Evidence Rating Level: 3 (Average)

Study Rundown: Seafood consumption is considered a mainstay of many healthy diets, particularly due to its macronutrient make-up, high in levels of the long-chain omega-3 fatty acids. However, seafood is also known to be a source of mercury, a neurotoxin, which when ingested in large amounts can lead to neurocognitive impairment, among other ailments. Despite potentially concerning levels of mercury, many seafood products also contain selenium, which serves to bind mercury and reduce its toxicity. With all of these potentially overlapping effects of seafood on neurological health, the purpose of this cross-sectional analysis was to study the association between neuropathologies like Alzheimer disease, dietary omega-3 fatty acids, and brain levels of mercury and selenium.

The study found that seafood consumption was indeed correlated with higher brain levels of mercury. However, mercury levels were not significantly associated with increased brain neuropathology. Overall an increased seafood consumption was associated with less Alzheimer pathology among those at the greatest risk of developing Alzheimer disease—APOE ε4 carriers. The relationship between seafood consumption and neuropathology was not significant among those without the APOE ε4 gene. This study was limited by a low proportion of participants completing the dietary questionnaires and a relatively narrow demographic spread. However, it is one of the first investigations into the effect of mercury levels on brain neuropathology. Future studies should widen the sample population while strengthening the number of participants with both dietary and pathological data.

Click to read the study, published today in JAMA

Relevant Reading: Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease

RELATED REPORTS

The 2 Minute Medicine Podcast Episode 6

#VisualAbstract: Lecanemab reduced cognitive and functional decline in early Alzheimer’s disease compared to placebo

Lecanemab may slow cognitive decline in early Alzheimer’s disease

In-Depth [cross-sectional study]: This cross-sectional analysis evaluated 286 autopsied brain specimens from deceased participants at the Rush Memory and Aging Project (MAP). Specimens were included among patients who died between November 2004 and November 2013 and who completed a dietary assessment prior to death. Brain cortical mercury levels were positively correlated with the number of seafood meals consumed per week (ρ 0.16,  p = 0.02). After adjusting for age, sex, education, and total energy intake, seafood consumption was significantly correlated with decreased risk of neuropathologically defined Alzheimer disease among APOE ε4 carriers (β −0.53 score units; 95%CI −0.96 to −0.10). Of note, further increases in omega-3 fatty acid supplementation was not correlated with any changes in the risk of Alzheimer pathology.

Image: CC/Wiki

©2016 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: Alzheimer’s disease
Previous Post

Dupilumab linked to improved symptoms in refractory chronic sinusitis and nasal polyposis

Next Post

Antibiotics not linked to improved recovery in acute malnutrition

RelatedReports

2MM Podcast

The 2 Minute Medicine Podcast Episode 6

January 13, 2023
#VisualAbstract: Lecanemab reduced cognitive and functional decline in early Alzheimer’s disease compared to placebo
StudyGraphics

#VisualAbstract: Lecanemab reduced cognitive and functional decline in early Alzheimer’s disease compared to placebo

January 12, 2023
Free alternatives comparable to Mini-Mental State Examination
Chronic Disease

Lecanemab may slow cognitive decline in early Alzheimer’s disease

January 10, 2023
The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
The Scan by 2 Minute Medicine®

The Scan by 2 Minute Medicine®: The Genetics of Alzheimer’s Disease, the Silent Killer, a Holiday Blizzard and an HIV Vaccine on the Horizon

January 11, 2023
Next Post
Oral amoxicillin as effective as injectable benzylpenicillin-gentamicin for infants with infection in which referral not possible [AFRINEST Trial]

Antibiotics not linked to improved recovery in acute malnutrition

Past marijuana exposure linked to impaired verbal memory

Past marijuana exposure linked to impaired verbal memory

Diet and physical activity promotion associated with decreased risk of type 2 diabetes

Metformin linked to reduced weight gain and improved insulin sensitivity in obese pregnant women without diabetes

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Chronic obstructive pulmonary disease associated with worse postoperative outcomes
  • Empagliflozin use is associated with slower progression of chronic kidney disease
  • Diagnostic tool may help identify cerebral palsy regardless of encephalopathy features
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options